PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy
PROTAC 介导的 NR4A1 降解作为癌症免疫治疗的新策略
期刊:Journal of Experimental Medicine
影响因子:12.6
doi:10.1084/jem.20231519
Lei Wang #, Yufeng Xiao #, Yuewan Luo, Rohan P Master, Jiao Mo, Myung-Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily Moser, Keiran S M Smalley, Dongwen Lv, Daohong Zhou,
